These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 21216258)
1. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Li N; Muthusamy S; Liang R; Sarojini H; Wang E Mech Ageing Dev; 2011 Mar; 132(3):75-85. PubMed ID: 21216258 [TBL] [Abstract][Full Text] [Related]
2. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Tabuchi T; Satoh M; Itoh T; Nakamura M Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258 [TBL] [Abstract][Full Text] [Related]
4. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Luan S; Sun L; Huang F Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934 [TBL] [Abstract][Full Text] [Related]
7. Murine microRNAs implicated in liver functions and aging process. Maes OC; An J; Sarojini H; Wang E Mech Ageing Dev; 2008 Sep; 129(9):534-41. PubMed ID: 18561983 [TBL] [Abstract][Full Text] [Related]
8. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway. Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Tryndyak VP; Ross SA; Beland FA; Pogribny IP Mol Carcinog; 2009 Jun; 48(6):479-87. PubMed ID: 18942116 [TBL] [Abstract][Full Text] [Related]
10. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Do MT; Kim HG; Choi JH; Jeong HG Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682 [TBL] [Abstract][Full Text] [Related]
11. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563 [TBL] [Abstract][Full Text] [Related]
12. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855 [TBL] [Abstract][Full Text] [Related]
13. Target identification of microRNAs expressed highly in human embryonic stem cells. Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598 [TBL] [Abstract][Full Text] [Related]
17. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876 [TBL] [Abstract][Full Text] [Related]
18. Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. Maes OC; Sarojini H; Wang E J Cell Physiol; 2009 Oct; 221(1):109-19. PubMed ID: 19475566 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes. Herbert KJ; Cook AL; Snow ET J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601 [TBL] [Abstract][Full Text] [Related]
20. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]